Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer

Overcoming tumor heterogeneity is a major challenge for personalized treatment of gastric cancer, especially for human epidermal growth factor receptor‐2 targeted therapy. Analysis of circulating tumor DNA allows a more comprehensive analysis of tumor heterogeneity than traditional biopsies in lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jing, Wang, Haixing, Zang, Wanchun, Li, Beifang, Rao, Guanhua, Li, Lei, Yu, Yang, Li, Zhongwu, Dong, Bin, Lu, Zhihao, Jiang, Zhi, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581520/
https://www.ncbi.nlm.nih.gov/pubmed/28677165
http://dx.doi.org/10.1111/cas.13314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581520/
https://www.ncbi.nlm.nih.gov/pubmed/28677165
http://dx.doi.org/10.1111/cas.13314

Ejemplares similares